ABIGAIL RUSSELL: Open Payments
NPI 1295300200 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 11 payments from 9 companies in 2025. Trend: 2023 $65 · 2024 $230 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Bioventus LLC | 3 | $102 |
| SPR Therapeutics, Inc | 1 | $37 |
| SI-BONE, INC. | 1 | $33 |
| Boston Scientific Corporation | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Acera Surgical, Inc. | 1 | $24 |
| Becton, Dickinson and Company | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Ossur Americas, Inc. | 1 | $14 |
Products named: DUROLANE, EXOGEN ULTRASOUND BONE HEALING SYSTEM, SPRINT PNS System, ACCOLADE SR, JOURNAVX, Restrata Wound Matrix, ARISTA, CAPLYTA.
Industry payments across TX — which companies pay providers there.
